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Abstract Case records and radiological investigations of
six children with benign fibrous histiocytoma were studied
retrospectively. BFH occurred in the femur (n = 2), tibia
(n = 2) and fibula (n = 2). Clinically, patients reported
pain from the lesion lasting several months (mean
6 months). The pain was not associated with pathological
fracture in any patient. On X-rays, the lesions appeared as
lytic and sharply demarcated with a sclerotic rim and fine
trabeculations. The reported cases were located in the
metaphysis and the diaphysis of the long bones. The
tumour was restricted to bone, without periosteal or soft
tissue reaction. Treatment consisted of careful intralesional
curettage of the lesion; the defect was thereafter filled with
bone bank graft or injectable phosphocalcic cement. The
length of follow-up ranged from 24 months to 4.75 years
(mean 35.2 months). One case presented with recurrence of
the disease and required successful repeat intralesional
curettage. Benign fibrous histiocytoma is probably under-
estimated among patients less than 20 years of age. This
diagnosis should be considered in any child or teenager
who presents with a non-ossifying fibroma accompanied by
unexplainable pain or a rapid growing. Surgery restricted to
the osteolytic lesion seems sufficient to achieve bone
healing.
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Introduction
Benign fibrous histiocytoma (BFH) is a rare skeletal
tumour accounting for approximatively 1% of all surgically
managed benign bone tumours [1]. This tumour is also
known as fibrous histiocytoma, xanthofibroma, fibroxan-
thoma of bone or primary xanthoma of bone [2–5]. Clini-
cally, patients report pain ranging in duration from months
to several years [3, 6, 7]. It is generally considered that
BFH occurs in patients after the age of 20 years [6–9].
Differentiation from non-ossifying fibroma is on purely
clinical grounds, since the histological features are identi-
cal [6, 8, 10]. In fact, BFH is composed of fibroblasts and
histiocytes that are arranged in a storiform pattern, similar
to non-ossifying fibroma and metaphyseal fibrous defects
[6, 8, 10]. Because the diagnostic criteria are very restric-
tive with regard to the age of the patient, BFH is seldom
diagnosed in patients under 20 years of age [6–9]. Because
of this fact, there are only 7 reports on BFH that have been
described in children and adolescents [2, 9, 11–15]. The
purpose of this study is to highlight BFH in a paediatric
population and discuss their clinical, radiological and
therapeutic features.
Materials and methods
After approval from the Children’s Hospital Review Board
(06-265R, Mat-Ped 06-048R), a retrospective review of
medical charts was performed to identify all children and
adolescents who have been surgically managed for sus-
pected benign fibrous histiocytoma at our institution from
January 1995 until December 2005. Based on clinical
records, demographics (age and sex), symptom duration,
laterality, and bone localization of BFH, treatment
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protocols and follow-up examinations were analysed.
Radiographic studies of the lesion were available for review
for each patient. Radiographic imaging included plain
radiographs, technetium bone scans, computed tomography
scans and MRI. Immediate postoperative and final follow-
up radiographs were reviewed to determine recurrence of
the lesion, if any. Intralesional curettage was performed for
every patient; the content of all lesions was examined his-
tologically. Thereafter, the patients were assessed clinically
and radiographically in regular follow-up sessions.
Cases reports
Case 1
A 14.7-year-old boy presented with pain of his left ankle
for more than 3 months. On physical examination, there
was no evidence of swelling or limitation of motion. Plain
radiographs demonstrated an eccentrically located and
radiolucent lesion with a ground-glass appearance in the
metaphysis of the distal end of the tibia. The lesion was
expansile, the cortex was thinned, and it had a prominent
marginal sclerosis. Intralesional curettage was performed
and phosphocalcic cement was employed for filling the
osseous defect. Thirty-three months after the intralesional
excision and filling of the lesion, bone healing was
achieved with phosphocalcic cement incorporation and no
evidence of disease (Figs. 1, 2, 3, 4, 5).
Case 2
A 13.75-year-old girl was seen after having pain in the left
ankle for more than 6 weeks. Physical examination was
negative. Plain radiographs demonstrated a well-defined
radiolucent lesion in the lower metaphyseal part of the tibia
with surrounding sclerosis. Forty months after intralesional
excision and bank bone grafting, bone healing was
achieved.
Case 3
A 9.5-year-old girl presented to our hospital complaining
of increasing right knee pain of 3 months duration. The
physical examination was unremarkable. On plain radiog-
raphy study, the right proximal fibula was totally involved
by lytic bone destruction. Thinning of the cortex and cor-
tical expansion were prominent. There was neither peri-
osteal reaction nor soft tissue invasion. The lesion quickly
increased in volume. Intralesional curettage was per-
formed, followed by insertion of phosphocalcic cement.
Twenty-five months after the operation, there was no evi-
dence of disease.
Case 4
A 12.2-year-old girl came to our clinic for evaluation a
painless lesion in the right lower femur discovered on a
radiograph due to pain around her right knee of 6 weeks
duration. Plain radiograph of the right distal femur showed
lytic bone destruction with surrounding sclerosis. No cal-
cification or periosteal reaction was observed. Intralesional
excision was performed with the insertion of phosphocalcic
cement, and there was no evidence of disease after
24 months of follow-up.
Case 5
A 10.75-year-old girl presented with 3 months of pain and
swelling around her right knee. Physical examination dis-
closed a hard painful mass in the distal part of the right
thigh. Plain radiograph showed a radiolucent lesion in the
metaphyseal part of the femur, with a soap-bubble
appearance. The lesion was expansile, the cortex was
thinned, and it had a prominent marginal sclerosis. Int-
ralesional curettage was performed, followed by filling of
the cavity by bank bone graft. The diagnosis of non-ossi-
fying fibroma was evocked on a histologically basis.
However, 18 months after the operation, the patient pre-
sented with small, lytic, recurrent foci in the lower part of
the old lesion. The lytic lesion grew progressively and was
suspected to be a giant cell tumour. Repeat intralesional
curettage was performed 2 years after the initial surgery.
Filling of the osseous cavity was performed with phos-
phocalcic cement; 39 months after the second surgical
procedure, the situation appeared to stabilize. Histologi-
cally, the tumour was composed of loose spindle cell
proliferation intermixed with foam cells. The diagnosis of
BFH was made based on clinical presentation, the radio-
logical features and recurrence of the lesion after the initial
surgery (Figs. 6, 7, 8, 9, 10, 11, 12, 13).
Case 6
A 14.3-year-old-girl was seen in our hospital complaining
of increasing right ankle pain of 2 years duration. The pain
resolved partially with the use of anti-inflammatory drugs.
X-rays demonstrated a well-defined, central radiolucent
lesion of the distal part of the peroneal diaphysis. The lytic
lesion grew progressively, was expansile and the cortex
was thinned. Intralesional excision of the lesion with pro-
phylactic osteosynthesis of the fibula was performed in
order to avoid pathological fracture after tumour resection.
Phosphocalcic cement was employed for filling the osseous
defect. Thirty-two months after the surgical procedure,
bone healing was achieved without evidence of recurrence
(Table 1).
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Histological features
The histological features of the six cases were similar, even if
the relative proportions of the various elements differed. The
tumour consisted of spindle cells, fibroblasts and histiocytic
mononucleated or multinucleated benign cells that were
intermixed with fibrous tissue. Spindle cells were arranged in
an interlacing and whorled pattern, frequently justifying the
designation ‘‘storiform’’. The tumour contained large areas
of ‘‘foam cells’’ and lipid-filled cells with abundant vacuo-
lated cytoplasm interspaced with small fibrovasular septu-
ations. No cellular atypia or pleomorphism was present;
Fig. 1 A 14.7-year-old boy presented with pain of his left ankle for
more than 3 months. Plain radiographs demonstrated an eccentrically
located and expansile radiolucent lesion in the metaphyseal of the
distal end of the tibia. The cortex was thinned and the lesion had a
prominent marginal sclerosis with a ground-glass appearance
Fig. 2 CT scans showed an irregular lytic area with well-defined
surrounding sclerotic bone
Fig. 3 On T1-weighted MR, the mass appeared hypointense, but the
surrounding rim of the lesion was of high signal intensity
Fig. 4 Intralesional curettage was performed and phosphocalcic
cement was employed for filling the osseous defect
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mitoses were scarce. Cholesterol clefts and haemosiderin
deposits were seen in some cases, and reparative new bone
formation was occasionally present. In all cases, the histo-
logical characteristics did not make it possible to make the
distinction between non-ossifying fibroma and benign
fibrous histiocytoma.
Discussion
Benign fibrous histiocytoma (BFH) constitutes a well-rec-
ognized tumour arising in the somatic soft tissue. Few
cases of this tumour have been reported in bone compared
with those in soft tissue [5, 6, 8]. BFH occurring in the
bone still raises controversy as many authors believe that it
should be considered as a separate entity [3]. A portion of
the confusion arises from the lack of agreement between
pathologists as to what exactly defines this lesion [3]. In
fact, there is no consensus as to whether this tumour rep-
resents a true neoplasm, a developmental defect or a
reactive process [3]. BFH is thought to have self-limited
processes and does not undergo malignant change or
metastasis [8]. However, BFH can be locally aggressive
and may recur after curettage [16]. Clinically, patients
usually report pain ranging in duration from months to
several years [3, 6, 7]. Pain may also be associated with
pathological fractures, but most of the time questioning
elicits a history of pain several weeks preceding the frac-
ture [8]. There may be local tenderness, but no mass or
swelling is noted as would be present with functional
impairment of the nearby joint. Radiologically, benign
fibrous histiocytomas are generally well-defined lytic
lesions, sometimes with sclerotic margins or cortical
expansion; they also have the appearance of a slow-
growing process [5–9, 17]. The lesion may have a loculated
appearance with septa or ridges or a soap-bubble appear-
ance [5, 6, 9]. The lesion occurs commonly in the spine,
ribs, pelvis [1, 5, 6, 8, 12, 15, 16, 18–22] or in the epiphysis
Fig. 5 Thirty-three months after surgery, bone healing was achieved
with advanced phosphocalcic cement incorporation and no evidence
of disease
Fig. 6 A 10.75-year-old girl presented with pain and swelling around
her right knee lasting 3 months. Physical examination disclosed a
hard painful mass in the distal part of the right thigh. Plain radiograph
showed a radiolucent lesion in the metaphyseal part of the femur with
a soap-bubble appearance. The lesion was expansile, the cortex was
thinned and showed prominent marginal sclerosis
Fig. 7 On T1-weighted MR, the mass appeared hypointense but the
surrounding rim of the lesion was of high signal intensity. The lesions
had the same signal intensity as skeletal muscle
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or diaphysis of tubular bones [5, 6, 8, 9, 11, 13, 17, 18]. In
another reports, this tumour occurred particularly around
the knee [6, 8, 9, 17]. There is neither periosteal reaction
nor matrix mineralization [5–8, 10]. On conventional
X-rays, the tumour may resemble non-ossifying fibroma,
but BFH may have more prominent marginal sclerosis
which may have the appearance of periosteal reaction in
juxtacortical lesions [3]. Many authors suggest that BFH
should not be distinguished from non-ossifying fibroma
solely on the basis of histological characteristics, which are
identical for the two lesions, but rather on clinical and
radiographic grounds [6, 8, 10, 17]. Pain has to be con-
sidered as the cardinal symptom and a median age over
20 years are considered factors that may differentiate
benign fibrous histiocytoma from other metaphyseal
fibrous lesions such as the non-ossifying fibroma [6–8, 10,
18]. Non-ossifying fibromas (NOF) almost always develop
in patients who are less than 20 years old and are consid-
ered to be developmental defects and self-limited processes
Fig. 8 The lesion turned hyperintense on T2-weighted images, with
the surrounding sclerotic bone having low signal intensity
Fig. 9 On bone scintigraphy, the lesion had moderate increased
uptake, but there was no scintigraphic argument for a pathological
fracture
Table 1 Recapitulative table
Case Age Sex Length
of pain
(months)
Site Treatment Length of
follow-up
monthsInitial Further
1 14.7 M 3 Lower metaphysis left tibia Intralesional curettage,
phosphocalcic cement
– 33
2 13.75 F 1.5 Lower metaphysis left tibia Intralesional curettage,
bank bone allograft
– 40
3 9.5 F 3 Upper diaphysis right peroneus Intralesional curettage,
phosphocalcic cement
– 25
4 12.2 F 1.5 Lower metaphysis right femur Intralesional curettage,
phosphocalcic cement
– 24
5 10.75 F 3 Lower metaphysis right femur Intralesional curettage,
bank bone allograft
Intralesional curettage,
phosphocalcic cement
57
6 14.3 F 24 Lower diaphysis right peroneus Intralesional curettage,
phosphocalcic cement
– 32
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[6, 8, 10]. Clinically, non-ossifying fibroma is most of the
time asymptomatic except in the case of pathological
fracture [6, 8, 9], whereas benign fibrous histiocytomas
frequently come to notice because of pain, usually of some
months duration [3, 6, 7]. As non-ossifying fibromas
spontaneously regress with skeletal maturity, surgical
treatment is reserved for the large lesions, usually after a
pathological fracture has occurred [23]. Moreover, these
two lesions are different clinically, and BFH possesses a
much more aggressive nature clinical than non-ossifying
fibroma [9, 10].
We do not agree with the opinion that the diagnostic
criteria of BFH must be so very restrictive with regard to
the age of the patient. In fact, the series of cases here
presented occurred in children and adolescents who were
symptomatic for a long time in the absence of pathological
fracture. Pain was most of the time described as a poorly
localized deep ache without relationship to the effort and
not prevailing during the night. The majority of the chil-
dren qualified the pain as awkward but nobody described it
as handicapping. In addition, pain due to the tumoral lesion
was likely to respond well to classic painkillers such as
anti-inflammatory drugs. In every case, the pain disap-
peared or changed in quality immediately after the resec-
tion of the BFH lesion. As the pain disappeared suddenly
after the surgery, it is difficult to charge it to a hypothetical
infra-radiological pathological fracture. Moreover, most of
the lesions we treated presented a prominent marginal
sclerosis, which constitutes a radiological difference
Fig. 10 Intralesional curettage was performed, followed by filling of
the cavity with bank bone graft; the diagnosis of non-ossifying
fibroma was evocked
Fig. 11 However, 18 months after the operation, the patient pre-
sented with small, lytic, recurrent foci in the lower part of the old
lesion
Fig. 12 The lytic lesion grew progressively and was suspected to be
a giant cell tumour. Repeated intralesional curettage 2 years after the
initial surgery was performed. As GCT was excluded by peri-
operative biopsy, filling of the osseous cavity was carried out with
phosphocalcic cement. Histologically, the tumour was composed
of loose spindle cell proliferation intermixed with foam cells. The
diagnosis of BFH was given because of the clinical presentation,
the radiological features noted and recurrence of the lesion after
the initial surgery
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between BFH and non-ossifying fibroma. At our opinion,
the diagnosis of BFH is probably underestimated among
patients less than 20 years old. Therefore, this diagnosis
should be considered, in our opinion, for any child or
teenager who presents radiologically a non-ossifying
fibroma accompanied by unexplainable pain or when the
lesion grows quickly. The differential diagnosis of this
lesion includes other clinical and pathological entities such
as fibrous dysplasia, chondromyxoid fibroma, giant cell
tumour of bone, eosinophilic granuloma, malignant fibrous
histiocytoma, metastatic renal cell carcinoma, Erdheim-
Chester disease or hyperparathyroidism. In adolescents and
young adults, one of the most difficult differential diag-
noses of BFH of metaphyseal-epiphyseal origin is giant
cell tumour [9]. The starting point of GCT is always
metaphyseal, and the lesion seldom extends to the epiph-
ysis before osseous maturity. GCT is rare in children and
adolescents less than 15 years old, in particular when the
cartilage is still active. GCT may have histological features
which are identical to those of benign fibrous histiocytoma;
in these cases, the diagnosis is usually established only on
the presence of small foci of typical histological patterns of
giant cell tumour of the bone [6, 9]. Therefore, one should
always keep in mind the small possibility of GCT of bone
if the lesion arises at the end of long tubular bone, even if
the patient is younger than 20 years of age.
Treatment consists of careful and complete curettage
and filling of the defect with graft material, bone cement or
other suitable bone void filler [3, 5, 6, 8, 9, 18]. The
treatments we have chosen for our patients consisted of
careful and complete curettage and filling of the defect
with bone bank allograft or phosphocalcic cement. In our
opinion, use of bone allograft can advantageously take the
place of autogenous bone graft as it gives the same results
and decreases postoperative morbidity. Currently, we use
more and more often phosphocalcic cement to fill the
lesion after excision of the tumour. The use of phospho-
calcic cement allows for better filling of the cavity com-
pared to bone grafts. Its greatest advantage compared to
conventional cement is that it can be reabsorbed and
incorporated in the bone and therefore does not constitute a
foreign body. The risk of recurrence is variable depending
on which series is consulted. One series [3, 8] of 8 cases
recurred locally and two required amputation. In the
Bertoni series, none of the 21 cases reported as xanthomas
recurred [5]. In another series, Bertoni et al. described 7
cases of BFH surgically treated without local recurrence,
just as in the Grohs publication where all the patients were
regarded as cured after prophylactic curettage and bone
grafting [6, 18]. As recurrence does not seem to be corre-
lated with the surgical margin achieved, surgery restricted
to the osteolytic lesion seems sufficient to achieve bone
healing [5, 6, 9, 18]. Therefore, it is stated that intralesional
curettage is sufficient to prevent recurrence. However,
recurrence may be due to an incomplete removal of the
pathological tissue [24]. So it appears important to carry
out the most complete removal of the tumoral tissue as is
possible. Milling the margins of the lytic lesion probably
allows for better excision of the pathological tissue and
would thus decrease the risk of recurrence.
Conclusion
Benign fibrous histiocytoma is probably underestimated
among patients less than 20 years of age. In our opinion,
the diagnostic criteria of BFH should not be so restrictive
with regard to the age of the patient, and this diagnosis
should be considered in any child or teenager who presents
radiologically with a non-ossifying fibroma accompanied
by unexplainable pain. Surgery restricted to the osteolytic
lesion seems sufficient to achieve bone healing. Recurrence
does not seem correlated with the surgical margin
achieved, but rather with an incomplete removal of the
tumoral tissue.
Conflict of interest None.
Fig. 13 Thirty-nine months after the second surgical procedure, the
situation appeared stabilized
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